, Bibliographie 1. World Health Organisation. Thirty-first report of the expert committee on drug dependence, Geneva: WHO, 1999.

, Collège National de Pharmacologie Médicale. Hypnotiques : Benzodiazépines et apparentés [Internet]. Site du Collège National de Pharmacologie Médicale Disponible sur, 2017.

, Disponible sur: http://www.pharmacovigilancelimoges .fr/sites, consommation des benzodiazépines en France [Internet]. ANSM. 2017 [cité 3 juill 2017ANSM_Rapport_Benzo_2017.pdf 4. Olfson M, King M, Schoenbaum M. Benzodiazepine Use in the United States, pp.136-178, 2015.

, Disponible sur: http://ansm.sante.fr/content/download, consommation de benzodiazépines en France [Internet]. ANSM. 2012, 2017.

, Notice patient: ZOLPIDEM MYLAN 10 mg, comprimé pelliculé sécable [Internet], Disponible sur

H. Autorité and D. Santé, Prise en charge du patient adulte se plaignant d'insomnie en médecine générale [Internet]. HAS Disponible sur: https://www.has-sante.fr/portail/jcms/c_522637/fr/prise-en-charge-du-patient-adulte- se-plaignant-d-insomnie-en-medecine-generale 8, 2006.

H. Autorité and D. Santé, Fiche de bon usage du médicament Quelle place pour les benzodiazépines dans l'insomnie? [Internet]. HAS, p.2017

, Disponible sur: https://www.has-sante.fr/portail, pp.2015-2018

H. Ashton, Guidelines for the Rational Use of Benzodiazepines, Drugs, vol.48, issue.1, pp.25-40, 1994.
DOI : 10.2165/00003495-199448010-00004

D. Dockhorn, Drugs and Insomnia: The Use of Medications To Promote Sleep [Internet] NIH Consens Statement Online Disponible sur : https://consensus.nih.gov Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial, Clin Neuropharmacol, vol.419, issue.104, pp.1-19333, 1983.

T. Roth, T. Roehrs, and G. Vogel, Zolpidem in the Treatment of Transient Insomnia: A Double-Blind, Randomized Comparison With Placebo, Sleep, vol.18, issue.4, pp.246-51, 1995.
DOI : 10.1093/sleep/18.4.246

J. Walsh, M. Erman, C. Erwin, A. Jamieson, M. Mahowald et al., Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia, Human Psychopharmacology: Clinical and Experimental, vol.44, issue.3, pp.191-199, 1998.
DOI : 10.1097/00004714-199006000-00005

A. Dang, A. Garg, and P. Rataboli, Role of Zolpidem in the Management of Insomnia, CNS Neuroscience & Therapeutics, vol.78, issue.suppl, pp.387-97, 2011.
DOI : 10.1159/000209348

T. Harrison and G. Keating, Zolpidem, CNS Drugs, vol.23, issue.6, pp.65-89, 2005.
DOI : 10.4088/JCP.v60n0806

T. Roehrs and T. Roth, Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem, Journal of Clinical Sleep Medicine, vol.12, issue.03, pp.319-344, 2016.
DOI : 10.5664/jcsm.5574

D. Kripke, Chronic hypnotic use: deadly risks, doubtful benefit, Sleep Medicine Reviews, vol.4, issue.1, pp.5-20, 2000.
DOI : 10.1053/smrv.1999.0076

M. Egan, Y. Moride, C. Wolfson, and J. Monette, Long-Term Continuous Use of Benzodiazepines by Older Adults in Quebec: Prevalence, Incidence and Risk Factors, Journal of the American Geriatrics Society, vol.52, issue.suppl 2, pp.811-817, 2000.
DOI : 10.1111/j.1532-5415.1991.tb02872.x

R. Shorr, S. Bauwens, and C. Landefeld, Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: Placing the elderly at risk, The American Journal of Medicine, vol.89, issue.6, pp.725-757, 1990.
DOI : 10.1016/0002-9343(90)90213-W

T. Inagaki, T. Miyaoka, S. Tsuji, Y. Inami, A. Nishida et al., Adverse Reactions to Zolpidem, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.12, issue.21, 2010.
DOI : 10.4088/PCC.09r00849bro

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067983/pdf

D. Buysse and . Insomnia, Insomnia, JAMA, vol.309, issue.7, pp.706-722, 2013.
DOI : 10.1001/jama.2013.193

G. Hajak, W. Müller, H. Wittchen, D. Pittrow, and W. Kirch, Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data, Addiction, vol.20, issue.Suppl 393, pp.1371-1379, 2003.
DOI : 10.2165/00002512-199303050-00006

J. Monti, D. Spence, K. Buttoo, and S. Pandi-perumal, Zolpidem???s use for insomnia, Asian Journal of Psychiatry, vol.25, pp.79-90, 2017.
DOI : 10.1016/j.ajp.2016.10.006

M. Terzano, M. Rossi, V. Palomba, A. Smerieri, and L. Parrino, New Drugs for Insomnia, Drug Safety, vol.14, issue.1, pp.261-82, 2003.
DOI : 10.2165/00002018-200326040-00004

C. Soldatos, D. Dikeos, and A. Whitehead, Tolerance and rebound insomnia with rapidly eliminated hypnotics, International Clinical Psychopharmacology, vol.14, issue.5, pp.287-303, 1999.
DOI : 10.1097/00004850-199909000-00004

B. Kolla, J. Lovely, M. Mansukhani, and T. Morgenthaler, Zolpidem is independently associated with increased risk of inpatient falls, Journal of Hospital Medicine, vol.8, issue.1, pp.1-6, 2013.
DOI : 10.1002/jhm.1985

S. Berry, Y. Lee, S. Cai, and D. Dore, Nonbenzodiazepine Sleep Medication Use and Hip Fractures in Nursing Home Residents, JAMA Internal Medicine, vol.173, issue.9, pp.754-61, 2013.
DOI : 10.1001/jamainternmed.2013.3795

URL : http://archinte.jamanetwork.com/data/journals/intemed/926956/iiq130125_754_761.pdf

F. Lin, P. Chen, C. Liao, Y. Hsieh, and F. Sung, Retrospective Population Cohort Study on Hip Fracture Risk Associated with Zolpidem Medication, Sleep, vol.52, issue.6, pp.673-682, 2014.
DOI : 10.1111/j.1532-5415.2004.52410.x

URL : https://academic.oup.com/sleep/article-pdf/37/4/673/13674830/aasm.37.4.673.pdf

M. Lai, C. Lin, C. Lin, C. Liu, T. Li et al., Long-Term Use of Zolpidem Increases the Risk of Major Injury: A Population-Based Cohort Study, Mayo Clinic Proceedings, vol.89, issue.5, pp.589-94, 2014.
DOI : 10.1016/j.mayocp.2014.01.021

S. Tom, E. Wickwire, Y. Park, and J. Albrecht, Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury, SLEEP, vol.39, issue.05, pp.1009-1023, 2016.
DOI : 10.5665/sleep.5742

URL : https://academic.oup.com/sleep/article-pdf/39/5/1009/13679344/aasm.39.5.1009.pdf

I. Gustavsen, J. Bramness, S. Skurtveit, A. Engeland, I. Neutel et al., Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam, Sleep Medicine, vol.9, issue.8, pp.818-840, 2008.
DOI : 10.1016/j.sleep.2007.11.011

Y. Yang, J. Lai, C. Lee, J. Wang, and P. Chen, Increased Risk of Hospitalization Related to Motor Vehicle Accidents Among People Taking Zolpidem: A Case???Crossover Study, Journal of Epidemiology, vol.21, issue.1, pp.37-43, 2011.
DOI : 10.2188/jea.JE20090195

J. Booth, M. Behring, R. Cantor, L. Colantonio, S. Davidson et al., Zolpidem use and motor vehicle collisions in older drivers, Sleep Medicine, vol.20, pp.98-102, 2016.
DOI : 10.1016/j.sleep.2015.12.004

N. Gunja, In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving, Journal of Medical Toxicology, vol.46, issue.1, pp.163-71, 2013.
DOI : 10.1177/009318531103900205

S. Gage, . De, Y. Moride, T. Ducruet, T. Kurth et al., Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, vol.349, issue.sep09 2, p.5205, 2014.
DOI : 10.1136/bmj.g5205

S. Billioti-de-gage, B. Bégaud, F. Bazin, H. Verdoux, J. Dartigues et al., Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, issue.sep27 4
DOI : 10.1136/bmj.e6231

Y. Yang, T. Hsieh, C. Yu, Y. Huang, C. Lee et al., Zolpidem and the risk of Parkinson's disease: A nationwide population-based study, Journal of Psychiatric Research, vol.58, pp.84-92, 2014.
DOI : 10.1016/j.jpsychires.2014.07.003

H. Huang, C. Tsai, C. Muo, K. Lin, M. Lu et al., Risk of Parkinson???s Disease Following Zolpidem Use, The Journal of Clinical Psychiatry, vol.76, issue.1, pp.104-110, 2015.
DOI : 10.4088/JCP.13m08790

, Organisation de l'addictovigilance [Internet]. ANSM Disponible sur: http://ansm.sante.fr/Declarer-un-effet-indesirable/Pharmacodependance- Addictovigilance, 2017.

, Fiche de surveillance renforcée: STILNOX et génériques Disponible sur: http://ansm.sante.fr/Activites/Surveillance-des-stupefiants-et- des-psychotropes/Medicaments-a-risque-d-usage-detourne-ou-de- dependance, Agence Nationale de Sécurité du Médicament et des produits de santé, p.2012, 2017.

A. Du-siriwardena, A. Qureshi, Z. Gibson, S. Collier, S. Latham et al., portant application d'une partie de la réglementation des stupéfiants aux médicaments à base de zolpidem administrés par voie orale. 42 GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics, Br J Gen Pract, vol.56, issue.533, pp.964-971, 2006.

F. Hoffmann, Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs [Internet], Disponible sur, 2013.

H. Everitt, L. Mcdermott, G. Leydon, H. Yules, D. Baldwin et al., GPs' management strategies for patients with insomnia: a survey and qualitative interview study, British Journal of General Practice, vol.64, issue.619, pp.112-121, 2014.
DOI : 10.3399/bjgp14X677176

B. Sivertsen, I. Nordhus, B. Bjorvatn, and S. Pallesen, Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway, Journal of Sleep Research, vol.44, issue.Suppl. 2, pp.36-41, 2010.
DOI : 10.1001/archpsyc.1985.01790260019002

, Réduire la sur-prescription de benzodiazépines et apparentés : quelles solutions ?, Collège National des Généralistes Enseignants, p.47

K. Mugunthan, T. Mcguire, and P. Glasziou, Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis, British Journal of General Practice, vol.61, issue.590, pp.573-581, 2011.
DOI : 10.3399/bjgp11X593857

R. Gould, M. Coulson, N. Patel, E. Highton-williamson, and R. Howard, Conclusions, British Journal of Psychiatry, vol.204, issue.02, pp.98-107, 2014.
DOI : 10.1192/bjp.bp.113.126003

. Formation-médicale-continue, Les MSU sont-ils des super-MG? [Internet]. FMC DINAN. 2015 [cité 5 nov 2017] Disponible sur: http://www.fmcdinan.org/2015/06/portrait-robot-des-generalistes-maitres-de-stage- les-msu-sont-ils-des-super-mg

F. Nicolas, Impacts de la maîtrice de stage sur l'exercice professionel des maîtres de stage universitaire en médecine générale, en région Haute-Normandie. [Thèse d'exercice], 2014.

, Sécurité d'emploi des médicaments psychotropes : point d'information sur le Rohypnol (flunitrazepam) [Internet]. ANSM Disponible sur: http://ansm.sante.fr/S-informer/Communiques-Communiques-Points-presse/Securite- d-emploi-des-medicaments-psychotropes-point-d-information-sur-le-Rohypnol- flunitrazepam 52, 2001.

, Point d'information sur le Rivotril® (clonazépam) : Modification des conditions de prescription et de délivrance [Internet]. ANSM Disponible sur: http://ansm.sante.fr/S-informer/Points-d-information-Points-d- information/Rivotril-R-clonazepam-Modification-des-conditions-de-prescription-et- de-delivrance-Point-d-information 53, Agence Nationale de Sécurité du Médicament et des produits de santé, 2011.

, Agence Française de Sécurité Sanitaire des Produits de Santé. Compte-rendu de la Commission Nationale des Stupéfiants et des Psychotropes de juin 2011 Disponible sur, 2011.

, Point d'information: Arrêt de commercialisation du Rohypnol [Internet]. ANSM 2013 Disponible sur: http://ansm.sante.fr/content, 2017.

C. Miller, L. Valenti, C. Harrison, D. Bartlett, N. Glozier et al., Time Trends in the Family Physician Management of Insomnia: The Australian Experience (2000???2015), Journal of Clinical Sleep Medicine, vol.13, issue.06, pp.785-790, 2017.
DOI : 10.5664/jcsm.6616

E. Sabuncu, J. David, C. Bernède-bauduin, S. Pépin, M. Leroy et al., Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683932/ 57. SurveyMonkey. Taille de l'échantillon de sondage: Évaluez le nombre de personnes à interroger [Internet]. SurveyMonkey. [cité 5 nov 2017]. Disponible sur: https://fr.surveymonkey.com/mp/sample-size/ 58, Conseil National de l'Ordre des Médecins. Atlas de la démographie médicale au 1er janvier 2016pdf 59. Collège National des Généralistes Enseignants et Syndicat National des Enseignants de Médecine Générale. Maitre de stage des universités et stages de médecine générale, 2002.